LifeStance Health Group, Inc. Common Stock Earnings Dividend

LifeStance Health Group, Inc. Common Stock’s revenue jumped 26.08% since last year same period to $435.35Mn in the Q2 2026. On a quarterly growth basis, LifeStance Health Group, Inc. Common Stock has generated 7.9% jump in its revenue since last 3-months.

LifeStance Health Group, Inc. Common Stock’s net profit jumped 722.84% since last year same period to $23.61Mn in the Q2 2026. On a quarterly growth basis, LifeStance Health Group, Inc. Common Stock has generated 65.78% jump in its net profits since last 3-months.

LifeStance Health Group, Inc. Common Stock’s net profit margin jumped 594.02% since last year same period to 5.42% in the Q2 2026. On a quarterly growth basis, LifeStance Health Group, Inc. Common Stock has generated 53.64% jump in its net profit margins since last 3-months.

LifeStance Health Group, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 0.03 - a -50% fall from last quarter’s estimates.

LifeStance Health Group, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 0.03.

LifeStance Health Group, Inc. Common Stock’s earning per share (EPS) jumped 700% since last year same period to 0.06 in the Q2 2026. This indicates that the LifeStance Health Group, Inc. Common Stock has generated 700% annual rate of jump in its earning per share (EPS) in the last 4 quarters.